Elo Madissoon
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Immunology top 10%
Papers in
-
- Single-cell and spatial transcriptomics 9
- Pluripotent Stem Cells Research 3
- Epigenetics and DNA Methylation 3
- CRISPR and Genetic Engineering 2
-
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 2
- Co-authors
- Outi Hovatta (5 shared papers)Shintaro Katayama (5 shared papers)Juha Kere (5 shared papers)Virpi Töhönen (4 shared papers)Liselotte Vesterlund (4 shared papers)Sten Linnarsson (3 shared papers)Thomas R. Bürglin (3 shared papers)Eeva‐Mari Jouhilahti (3 shared papers)
- Journals
- Nature Medicine (3 papers)Nature Communications (2 papers)Nature (2 papers)Scientific Reports (2 papers)Brain (1 paper)
- Partner nations
- United KingdomSwedenGermany
In The Last Decade
Elo Madissoon
18 papers receiving 2.7k citations
Elo Madissoon's Hit Papers
Peers
Comparison fields: 5 of 122
- Infectious Diseases 924
- Immunology 380
- Molecular Biology 1.1k
- Biophysics 85
- Pulmonary and Respiratory Medicine 383
Countries citing papers authored by Elo Madissoon
This map shows the geographic impact of Elo Madissoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elo Madissoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elo Madissoon more than expected).
Fields of papers citing papers by Elo Madissoon
This network shows the impact of papers produced by Elo Madissoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elo Madissoon. The network helps show where Elo Madissoon may publish in the future.
Co-authors
The 25 scholars most cited alongside Elo Madissoon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity Hit paper breakdown → | 2022 | 792 |
| 2 | An integrated cell atlas of the lung in health and disease Hit paper breakdown → | 2023 | 425 |
| 3 | 2019 | 316 | |
| 4 | Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics Hit paper breakdown → | 2021 | 260 |
| 5 | 2021 | 227 | |
| 6 | 2022 | 145 | |
| 7 | 2022 | 131 | |
| 8 | 2021 | 122 | |
| 9 | 2015 | 91 | |
| 10 | 2016 | 50 | |
| 11 | 2016 | 49 | |
| 12 | 2024 | 43 | |
| 13 | 2014 | 25 | |
| 14 | 2022 | 20 | |
| 15 | 2019 | 14 | |
| 16 | 2019 | 8 | |
| 17 | 2023 | 5 | |
| 18 | 2025 | 4 |
About Elo Madissoon
Elo Madissoon is a scholar working on Molecular Biology, Infectious Diseases, Pulmonary and Respiratory Medicine, Immunology and Cancer Research, having authored 18 papers that have together received 2.7k indexed citations. Recurring topics across this work include Single-cell and spatial transcriptomics (9 papers), Neonatal Respiratory Health Research (4 papers), Pluripotent Stem Cells Research (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Epigenetics and DNA Methylation (3 papers), CRISPR and Genetic Engineering (2 papers), COVID-19 Clinical Research Studies (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Infectious Diseases (924 citations), Immunology (380 citations), Molecular Biology (1.1k citations), Biophysics (85 citations) and Pulmonary and Respiratory Medicine (383 citations). Elo Madissoon has collaborated with scholars based in United Kingdom, Sweden and Germany. Frequent co-authors include Outi Hovatta, Shintaro Katayama, Juha Kere, Virpi Töhönen, Liselotte Vesterlund, Sten Linnarsson, Thomas R. Bürglin, Eeva‐Mari Jouhilahti, Sarah Amalia Teichmann and Kaarel Krjutškov. Their work appears in journals such as Nature Medicine, Nature Communications, Nature, Scientific Reports and Brain.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.